Literature DB >> 11734937

Role of contrast-enhanced helical CT in the evaluation of acute thoracic aortic injuries after blunt chest trauma.

M Scaglione1, A Pinto, F Pinto, L Romano, A Ragozzino, R Grassi.   

Abstract

The purpose of this retrospective study was to determine the value of contrast-enhanced helical CT for detecting and managing acute thoracic aortic injury (ATAI). Between June 1995 and February 2000, 1419 consecutive chest CT examinations were performed in the setting of major blunt trauma. The following CT findings were considered indicative of ATAI: intimal flap; pseudoaneurysm; contour irregularity; lumen abnormality; and extravasation of contrast material. On the basis of these direct findings no further diagnostic investigations were performed. Isolated mediastinal hematoma on CT scans was considered an indirect sign of ATAI: In these cases, thoracic aortography was performed even if CT indicated normal aorta. Seventy-seven patients had abnormal CT scans: Among the 23 patients with direct CT signs, acute thoracic aortic injuries was confirmed at thoracotomy in 21. Two false-positive cases were observed. The 54 remaining patients had isolated mediastinal hematoma without aortic injuries at CT and corresponding negative angiograms. The 1342 patients with negative CT scans were included in the 8-month follow-up program and did not show any adverse sequela based on clinical and radiographic criteria. Contrast-enhanced helical CT has a critical role in the exclusion of thoracic aortic injuries in patient with major blunt chest trauma and prevents unnecessary thoracic aortography. Direct CT signs of ATAI do not require further diagnostic investigations to confirm the diagnosis: Isolated aortic bands or contour vessel abnormalities should be first considered as possible artifacts or related to non-traumatic etiologies especially when mediastinal hematoma is absent. In cases of isolated mediastinal hematoma other possible sources of bleeding should be considered before directing patients to thoracic aortography.

Entities:  

Mesh:

Year:  2001        PMID: 11734937     DOI: 10.1007/s003300100836

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  6 in total

1.  Dual-source dual-energy CT: dose reduction after endovascular abdominal aortic aneurysm repair.

Authors:  Vitaliano Buffa; Antonio Solazzo; Valeria D'Auria; Alessandra Del Prete; Andrea Vallone; Monica Luzietti; Manuela Madau; Roberto Grassi; Vittorio Miele
Journal:  Radiol Med       Date:  2014-07-02       Impact factor: 3.469

2.  25th Anniversary of European Radiology.

Authors:  Maximilian F Reiser
Journal:  Eur Radiol       Date:  2017-01       Impact factor: 5.315

Review 3.  Diagnosing traumatic rupture of the thoracic aorta in the emergency department.

Authors:  C E O'Conor
Journal:  Emerg Med J       Date:  2004-07       Impact factor: 2.740

Review 4.  Dual-phase CT for the assessment of acute vascular injuries in high-energy blunt trauma: the imaging findings and management implications.

Authors:  Francesca Iacobellis; Anna M Ierardi; Maria A Mazzei; Alberto Magenta Biasina; Gianpaolo Carrafiello; Refky Nicola; Mariano Scaglione
Journal:  Br J Radiol       Date:  2016-02-17       Impact factor: 3.039

5.  ACR Appropriateness Criteria(®) blunt chest trauma--suspected aortic injury.

Authors:  Shadpour Demehri; Frank J Rybicki; Benoit Desjardins; Chieh-Min Fan; Scott D Flamm; Christopher J Francois; Marie D Gerhard-Herman; Sanjeeva P Kalva; Hyun S Kim; M Ashraf Mansour; Emile R Mohler; Isabel B Oliva; Matthew P Schenker; Clifford Weiss; Karin E Dill
Journal:  Emerg Radiol       Date:  2012-03-18

Review 6.  Traumatic fractures in adults: missed diagnosis on plain radiographs in the Emergency Department.

Authors:  Antonio Pinto; Daniela Berritto; Anna Russo; Federica Riccitiello; Martina Caruso; Maria Paola Belfiore; Vito Roberto Papapietro; Marina Carotti; Fabio Pinto; Andrea Giovagnoni; Luigia Romano; Roberto Grassi
Journal:  Acta Biomed       Date:  2018-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.